Etelcalcetide hydrochlorideProduct ingredient for Etelcalcetide
- Name
- Etelcalcetide hydrochloride
- Drug Entry
- Etelcalcetide
Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
- Accession Number
- DBSALT002195
- Structure
Structure for Etelcalcetide hydrochloride (DBSALT002195)
- Synonyms
- Etelcalcetide HCl / Telcalcetide hydrochloride / Velcalcetide hydrochloride
- External IDs
- AMG 416